Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens

por Dorey, Lucy, Lees, Peter
Publicado 2017

Sun Cluster 3 programming: integrating applications into the SunPlex environment

por Bianco, Joseph, Lees, Peter, Rabito, Kevin
Publicado 2005

Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling

por Dorey, Lucy, Pelligand, Ludovic, Lees, Peter
Publicado 2017

The Decline and Fall of Materia Medica and the Rise of Pharmacology and Therapeutics in Veterinary Medicine

por Lees, Peter, Bäumer, Wolfgang, Toutain, Pierre-Louis
Publicado 2022

Pharmacokinetic/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida

por Dorey, Lucy, Pelligand, Ludovic, Cheng, Zhangrui, Lees, Peter
Publicado 2017

Semi-Mechanistic Modeling of Florfenicol Time-Kill Curves and in silico Dose Fractionation for Calf Respiratory Pathogens

por Pelligand, Ludovic, Lees, Peter, Sidhu, Pritam Kaur, Toutain, Pierre-Louis
Publicado 2019

Pragmatic Systemic Solutions to the Wicked and Persistent Problem of the Unprofessional Disruptive Physician in the Health System

por Peisah, Carmelle, Williams, Betsy, Hockey, Peter, Lees, Peter, Wright, Danette, Rosenstein, Alan
Publicado 2023

VetCAST Method for Determination of the Pharmacokinetic-Pharmacodynamic Cut-Off Values of a Long-Acting Formulation of Florfenicol to Support Clinical Breakpoints for Florfenicol A...

por Toutain, Pierre-Louis, Sidhu, Pritam Kaur, Lees, Peter, Rassouli, Ali, Pelligand, Ludovic
Publicado 2019

Veterinary Medicine Needs New Green Antimicrobial Drugs

por Toutain, Pierre-Louis, Ferran, Aude A., Bousquet-Melou, Alain, Pelligand, Ludovic, Lees, Peter
Publicado 2016

Extended followup of a cohort of chromium production workers

por Gibb, Herman Jones, Lees, Peter St. John, Wang, Jing, Grace O'Leary, Keri
Publicado 2015

Peak Exposures in Epidemiologic Studies and Cancer Risks: Considerations for Regulatory Risk Assessment

por Checkoway, Harvey, Lees, Peter S. J., Dell, Linda D., Gentry, P. Robinan, Mundt, Kenneth A.
Publicado 2019

Pharmacology, safety, efficacy and clinical uses of the COX‐2 inhibitor robenacoxib

por Lees, Peter, Toutain, Pierre‐Louis, Elliott, Jonathan, Giraudel, Jerome M., Pelligand, Ludovic, King, Jonathan N.
Publicado 2022

Biased computation of probability of target attainment for antimicrobial drugs

por Toutain, Pierre‐Louis, Gandia, Peggy, Pelligand, Ludovic, Ferran, Aude A., Lees, Peter, Bousquet‐Mélou, Alain, Concordet, Didier
Publicado 2023

A study of urban housing demolitions as sources of lead in ambient dust: demolition practices and exterior dust fall.

por Farfel, Mark R, Orlova, Anna O, Lees, Peter S J, Rohde, Charles, Ashley, Peter J, Chisolm, J Julian
Publicado 2003

Prenatal Secondhand Smoke Exposure and Infant Birth Weight in China

por Lee, Nora L., Samet, Jonathan M., Yang, Gonghuan, Zhou, Maigeng, Yang, Jie, Correa, Adolfo, Lees, Peter S. J.
Publicado 2012

Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?

por Concordet, Didier, Gandia, Peggy, Montastruc, Jean-Louis, Bousquet-Mélou, Alain, Lees, Peter, Ferran, Aude, Toutain, Pierre-Louis
Publicado 2019

Formaldehyde Exposure and Mortality Risks From Acute Myeloid Leukemia and Other Lymphohematopoietic Malignancies in the US National Cancer Institute Cohort Study of Workers in Form...

por Checkoway, Harvey, Dell, Linda D., Boffetta, Paolo, Gallagher, Alexa E., Crawford, Lori, Lees, Peter SJ., Mundt, Kenneth A.
Publicado 2015

Authors’ Reply to Nicolas: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”

por Concordet, Didier, Gandia, Peggy, Montastruc, Jean-Louis, Bousquet-Mélou, Alain, Lees, Peter, Ferran, Aude A., Toutain, Pierre-Louis
Publicado 2019

Authors’ Reply to Coste et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”

por Concordet, Didier, Gandia, Peggy, Montastruc, Jean-Louis, Bousquet-Mélou, Alain, Lees, Peter, Ferran, Aude A., Toutain, Pierre-Louis
Publicado 2019

Authors’ Reply to Castello-Bridoux et al.: “Comment on Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”

por Concordet, Didier, Gandia, Peggy, Montastruc, Jean-Louis, Bousquet-Mélou, Alain, Lees, Peter, Ferran, Aude A., Toutain, Pierre-Louis
Publicado 2019